e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Animal and
ex vivo
models of airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Counteracting effects of apigenin and leptin on lung adenocarcinoma cells
A. Bruno, L. Siena, E. Pace, S. Gerbino, P. Chanez, M. Ferraro, M. Profita, M. Giammanco, V. Bellia, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Montpellier, France)
Source:
Annual Congress 2007 - Animal and
ex vivo
models of airway inflammation
Session:
Animal and
ex vivo
models of airway inflammation
Session type:
Thematic Poster Session
Number:
899
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bruno, L. Siena, E. Pace, S. Gerbino, P. Chanez, M. Ferraro, M. Profita, M. Giammanco, V. Bellia, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Montpellier, France). Counteracting effects of apigenin and leptin on lung adenocarcinoma cells. Eur Respir J 2007; 30: Suppl. 51, 899
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Leptin and apigenin: antagonists in the apoptotic pathway of lung adenocarcinoma cell line
Source: Eur Respir J 2006; 28: Suppl. 50, 668s
Year: 2006
Inhibitory effects of mitochondrial TRAP1 on gefitinib-resistancein non-small lung cancer cells
Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms
Year: 2018
Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Deguelin enhances chemosensitivity of non-small cell lung cancer cells
Source: Eur Respir J 2006; 28: Suppl. 50, 336s
Year: 2006
The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007
Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010
The influence of non-small cell lung cancer cells on the expression of adipokines in brown adipose tissue
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
The influence of brown adipose tissue on the proliferation and chemosensitivity in non-small cell lung cancer cells
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Prx1 provides resistance to docetaxel-induced apoptosis in lung cancer cells
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Inhibitory effects of shRNA targeting twist on epithelial-mesenchymal transition and invasion ability of human lung carcinoma cell A549
in vitro
Source: Eur Respir J 2006; 28: Suppl. 50, 325s
Year: 2006
Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Autophagy induces cytoprotection in cisplatin-treated lung cancer cells
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
The effect of SDF-1/CXCR4 on expression of VEGF and MMP-9 in small cell lung cancer
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006
Selective apoptosis of lung cancer cells with talc
Source: Eur Respir J 2010; 35: 450-452
Year: 2010
Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept